Results 21 to 30 of about 149,298 (164)

Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice

open access: yesnpj Vaccines, 2023
Development of SARS-CoV-2 vaccines that protect vulnerable populations is a public health priority. Here, we took a systematic and iterative approach by testing several adjuvants and SARS-CoV-2 antigens to identify a combination that elicits antibodies ...
Etsuro Nanishi   +30 more
doaj   +1 more source

Cancer vaccines [PDF]

open access: yesPhilosophical Transactions of the Royal Society B: Biological Sciences, 2011
Abstract While vaccines are primarily thought of in terms of their use for prevention of infectious diseases, they can potentially be used to prevent or treat cancer. This manuscript explores the rationale for vaccines and immunotherapies for cancer from both the scientific and the global needs perspectives.
openaire   +4 more sources

Aging, cancer, and cancer vaccines [PDF]

open access: yesImmunity & Ageing, 2012
AbstractWorld population has experienced continuous growth since 1400 A.D. Current projections show a continued increase - but a steady decline in the population growth rate - with the number expected to reach between 8 and 10.5 billion people within 40 years.
MAZZOLA, PAOLO   +6 more
openaire   +3 more sources

Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects

open access: yesCell Reports, 2021
Summary: SARS-CoV-2 is one of three coronaviruses that have crossed the animal-to-human barrier and caused widespread disease in the past two decades. The development of a universal human coronavirus vaccine could prevent future pandemics.
Madeleine F. Jennewein   +28 more
doaj   +1 more source

Cancer vaccines

open access: yesBritish Journal of Surgery, 2007
Stormy ...
R, Kiessling, A, Choudhury
openaire   +2 more sources

Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy

open access: yesOncoImmunology, 2017
Purpose: Although local oncolytic viral therapy (OVT) may enhance tumor lysis, antigen release, and adaptive immune responses, systemic antitumor responses post-therapy are limited. Adoptive immunotherapy with autologous dendritic cells (DC) and cytokine-
Jun Ren   +13 more
doaj   +1 more source

Cancer Microenvironment and Cancer Vaccine [PDF]

open access: yesCancer Microenvironment, 2012
The cancer microenvironment is constituted of non-transformed host stromal cells such as endothelial cells, fibroblasts, various immune cells, and a complex extra-cellular matrix secreted by both the normal and neoplastic cells embedded in it. The importance of the microenvironment and its potential in cancer therapy is just being established.
Zhen-Yu, Ding   +2 more
openaire   +2 more sources

Complete Rescue of HTLV-1p12KO Infectivity by Depletion of Monocytes Together with NK and CD8+ T Cells

open access: yesPathogens
The transient depletion of monocytes alone prior to exposure of macaques to HTLV-1 enhances both HTLV-1WT (wild type) and HTLV-1p12KO (Orf-1 knockout) infectivity, but seroconversion to either virus is not sustained over time, suggesting a progressive ...
Anna Gutowska   +12 more
doaj   +1 more source

Cancer vaccines in the clinic

open access: yesBioengineering & Translational Medicine, 2023
AbstractVaccines are an important tool in the rapidly evolving repertoire of immunotherapies in oncology. Although cancer vaccines have been investigated for over 30 years, very few have achieved meaningful clinical success. However, recent advances in areas such antigen identification, formulation development and manufacturing, combination therapy ...
Morgan E. Janes   +4 more
openaire   +3 more sources

Therapeutic cancer vaccines: Where do we stand?

open access: yesJournal of Integrative Medicine and Research, 2023
Vaccines and immunotherapy have transformed the treatment modalities and prevention of several diseases including malignancy. Vaccines for infectious diseases have been in use for many decades, but very few cancer vaccines are approved for human use ...
Rajlaxmi Sarangi   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy